Professional Documents
Culture Documents
American Academy of
692 Correspondence
Dermatology
potential of the eye and is a sensitive measure of the Isotretinoin may adversely influence cone- and pos-
functional integrity of the retinal pigment epithelium sibly rod-mediated dark adaptation in a small proportion
(RPE). of patients. It is not known if isotretinoin could interfere
ERG showed subnormal dark-adapted cone-me- with vitamin A function within the retina. We have
diated and, to a lesser degree, dark-adapted rod-me- begun a study to evaluate prospectively this possible
diated responses in two of three patients tested. EOG effect on retinal function in acne patients taking iso-
was subnormal in one of three patients tested. Dark tretinoin.
adaptometry revealed elevation of the cone, and in some
Susan Denman, M.D.,* Richard We leber, M.D.,**
instances rod, thresholds in all patients tested. Visual
Jon M. Hanifin, M.D., *
fields, visual acuity, and funduscopic examinations
William Cunningham, M.D.,*** Clnd
were normal in all patients tested. Subjective improve-
Richard Phipps, MD. *
ment had occurred with drug cessation in all patients
Departments of Dermatology* and Ophthalmology, **
and follow-up ERG had normalized in one patient re-
The Oregon Health Sciences University,
tested.
Portland, OR, and Hoffmann-La Roche Inc., ***
Since being apprised of these findings, one of us
Nutley, NJ
CR. P.) has elicited symptoms of decreased night vision
in two patients treated for acne in his private office. REFERENCE
One had mild elevation of both the rod and cone thresh-
1. Weleber RG, Denman ST, Cunningham WC, Hanifin JM:
olds as determined by dark adaptometry, but a normal Abnormal night vision, dark adaptation and electrophys-
ERG. We have not as yet tested retinal function of the iologic responses associated with isotretinoin therapy for
second patient. acne. Clin Res 33:158A, 1985.
ABSTRACTS
Delusions of infestation treated with pimozide: A Isolation of human t-lymphotropic virus type III
follow-up study from the tears of a patient with the acquired
Lindskov R, Baadsgaard 0: Acta Derm Venereol immunodeficiency syndrome
(Stockh) 65:267-270, 1985 Fujikawa LS, Salahuddin 5Z, Palestine AG, et al:
Lancet 2:529-530, 1985
Monosymptomatic delusions of infestation in fourteen pa-
tients were followed up 19 to 48 months after treatment with Human T lymphotropic virus type III has previously been
pimozide was terminated. Dosages were up to 4 mg daily, isolated from lymphocytes in the peripheral blood, bone mar-
with improvement noted in 2 to 4 weeks in all but one of the row cells, lymph nodes, brain, saliva, semen, and cell-free
patients. Seven patients remained completely free of symp- plasma. I~ this study the virus was isolated from tears of one
toms during follow-upof 19 to 48 months after termination patient with the acquired immunodeficiency syndrome.
of treatment. Three patients had recurrences after termination J. Graham Smith, Jr., M.D.
of treatment; four patients had symptoms during follow-up
or only moderate relief with therapy. Prophylactic antibiotics in cutaneous surgery
J. Graham Smith, Jr., M.D.
Sebben JE: J Dermatol Surg OncoI1l:901-906, 1985
Ketoconazole for hirsutism Antibiotics have no effect on the incidence of infection in
Carvalho 0, Pignatelli D, Resende C: Lancet 2:560, clean, uncomplicated surgical wounds. Infection rate is re-
1985 duced when prophylaxis is used in clean-contaminated and
contaminated surgical wounds. Maximum effects are achieved
A 27-year-old woman with hirsutism and polycystic ova- by presence of the drug in the tissue at the time of wounding.
ries had striking improvement of hirsutism after 200 mg of Antibiotics should be given for 24 to 48 hours longer; how-
ketoconazole twice daily for 2 months. Because of liver func- ever, more prolonged treatment provides no greater protection
tion abnormalities, the drug was stopped; however, improve- from infection. The most satisfactory drugs are cephalosporin
ment was noted at 4 months after cessation of therapy. and erythromycin by the oral route.
J. Graham Smith, Jr.. M.D. J. Graham Smith, Jr., M.D.